12 min read | Unique research highlights an overlooked mental health disparity among Indigenous North American people with HD – and the need for care grounded in trust, community partnership, and ...
HDBuzz has been following SKY-0515 since the first results from its Phase 1 study were announced in 2024. Early testing in ...
In plain language. Written by scientists. Roche gave an update this week about GENERATION HD2, testing the HTT-lowering drug tominersen in people with HD. The trial is continuing, but only the higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results